News
Stay Ahead with the Latest Industry Trends & Market Insights with Industry News đź“°

Middle East and Africa Digital Therapeutic Market Size, Share, and Outlook (2024-2031)

Published: November 2023 || SKU: HCIT7403
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
Get Free Sample

Get Expert Insights on Middle East and Africa Digital Therapeutic Market

Talk to analysts, not algorithms.

Middle East and Africa Digital Therapeutics Market is Segmented Digital Therapeutics Market is segmented By Product Type (Software, Devices, Others), By Application (Diabetes, Obesity, Cardiovascular Diseases (CVD), Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Gastrointestinal Disorders (GID), Others), By Sales Channel (Business-to-Business (B2B) (Employer, Healthcare Providers, Payers, Pharmaceutical Companies, Others), Business-to-Consumer (B2C) (Patient, Caregiver)), and By Country (UAE,KSA, Israel) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.

Middle East and Africa Digital Therapeutics Market Overview

Middle East and Africa Digital Therapeutics Market is expected at a CAGR of 23.4% during the forecast period.

Digital therapeutics is a healthcare solution and treatment option that uses digital technologies to cure patients with medical or psychological problems. It offers a new approach to disease management by using high-quality software and systems to assist patients in monitoring their health conditions at home. These solutions use the internet infrastructure, smartphones, and advanced technologies such as artificial intelligence (AI), machine learning, and big data analytics to customize the treatment to the patient. 

The digital therapeutics market includes various products such as telemedicine platforms, apps, wearable devices, and others. Currently, there are many healthcare apps and wearable devices that are easily accessible worldwide.

Middle East and Africa Digital Therapeutics Market Scope

Metrics

Details

CAGR

23.4%

Size Available for Years

2021-2030

Forecast Period

2023-2030

Data Availability

Value (US$) 

Segments Covered

Product Type, Application, Sales Channel, and Country

Countries Covered

KSA, UAE, Israel

Largest Country

UAE

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.

 

For more details on this report - Request for Sample

 

Middle East and Africa Digital Therapeutics Market Dynamics

Increasing patient demand for digital therapeutics is poised for continued growth.

The growing adoption of technological advancements in digital therapeutics is contributing to the growth of the MEA digital therapeutics market. Healthcare providers and researchers have been working together to develop digital therapeutics for oncology, cardiovascular diseases and others. Manufacturers also focus on developing digital therapeutics with advanced features like big data and artificial intelligence to ensure the best possible design, clinical support and data security. 

Furthermore, they manufacture medical products used in digital therapeutics to monitor and track patients' health throughout treatment. The wide range of applications for digital therapeutics, including promoting adherence to prescribed treatments, diets, and exercise regimens, also contribute to the market's growth. With the ongoing development of cutting-edge technologies and increasing patient demand, the market for digital therapeutics is poised for continued growth.

Middle East and Africa Digital Therapeutics Market Segment Analysis

Middle East America and Africa Digital Therapeutics Market is segmented into product type, application, sales channel and country

By Product Type 

  • Software 
  • Devices 
  • Others

By Application 

  • Diabetes
  • Obesity
  • Cardiovascular Diseases (CVD)
  • Central Nervous System (CNS) Diseases
  • Respiratory Diseases
  • Smoking Cessation
  • Gastrointestinal Disorders (GID)
  • Others

By Sales Channel 

  • Business-to-Business (B2B) 
    • Employer
    • Healthcare Providers
    • Payers
    • Pharmaceutical Companies
    • Others
  • Business-to-Consumer (B2C)
    • Patient
    • Caregiver

By Country

  • KSA
  • UAE
  • Israel

Middle East and Africa Digital Therapeutics Market Regional Analysis

The Middle East and Africa Digital Therapeutics Market can be segmented into KSA, UAE, Israel 

The Middle East and Africa accounted for a moderate share of the global market in 2022. However, during the forecast period, the regional market is expected to grow at a healthy CAGR due to the increasing focus of international market participants on capturing the potential of the MEA region. The healthcare infrastructure in the MEA region is improving, and the number of initiatives by the governments of MEA countries in favor of digital healthcare is increasing. Moreover, the growing prevalence of chronic diseases is driving the demand for advanced healthcare solutions. Among the MEA countries, the UAE is expected to hold a significant share of the market during the forecast period. This is due to the large and relatively younger population that presents a substantial target base, rapid urbanization, and digitization. Additionally, ongoing reforms to address inadequate infrastructure and ensure sustainable growth through financial inclusion are expected to have a positive impact on the market.

Major Key Players in the Market

The major players covered in the Middle east and Africa digital therapeutic market report are Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AG (Pear Therapeutics, Inc.), Resmed, Inc. (Propeller Health), Voluntis, Inc., Ada Health GmbH, Cognifit ltd, Caterna Vision GmbH, Sonormed GmbH, and Kaia Health are playing a leading role in the APAC digital therapeutics market

Why purchase Middle East and Africa Digital Therapeutic Market report?

Technological Innovations

Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.

Product Performance & Market Positioning

Analyzes product performance, market positioning, and growth potential to optimize strategies.

Real-World Evidence

Integrates patient feedback and data into product development for improved outcomes.

Physician Preferences & Health System Impact

Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.

Market Updates & Industry Changes

Covers recent regulatory changes, new policies, and emerging technologies.

Competitive Strategies

Analyzes competitor strategies, market share, and emerging players.

Pricing & Market Access

Reviews pricing models, reimbursement trends, and market access strategies.

Market Entry & Expansion

Identifies optimal strategies for entering new markets and partnerships.

Regional Growth & Investment

Highlights high-growth regions and investment opportunities.

Supply Chain Optimization

Assesses supply chain risks and distribution strategies for efficient product delivery.

Sustainability & Regulatory Impact

Focuses on eco-friendly practices and evolving regulations in healthcare.

Post-market Surveillance

Uses post-market data to enhance product safety and access.

Pharmacoeconomics & Value-Based Pricing

Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2025

Manufacturers

Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.

Regulatory & Policy

Compliance Officers, Government, Health Economists, Market Access Specialists.

Application & Innovation

AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.

Investors

Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.

Consulting & Advisory

Healthcare Consultants, Industry Associations, Analysts.

Supply Chain

Distribution and Supply Chain Managers.

Consumers & Advocacy

Patients, Advocacy Groups, Insurance Companies.

Academic & Research

Academic Institutions.

Buy this report
Single User
$3750$3000
Multiple User
$4000$3200
Enterprise User
$7250$5800
Proceed to Buy
  Get Free Sample
  Customize Sample
  Demo Full Report
Chat on WhatsApp
WhatsApp